[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335409-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335409-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-movement-of-mitochondria-in-breast-cancer-internal-motility-and-intercellular-transfer-of-mitochondria","The movement of mitochondria in breast cancer - internal motility and intercellular transfer of mitochondria","","Mitochondria function as central energy sources that regulate cancer cell growth, proliferation, migration, and cell fate decisions. The document examines how mitochondrial movement shapes breast cancer progression, both within cells to match local energetic demands and between cells through intercellular donation mechanisms such as tunneling nanotubes. Mitochondrial transfer is linked to increased aggressiveness and chemoresistance, motivating efforts to define underlying mechanisms. Understanding mitochondrial biology supports development of targeted therapeutics.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-movement-of-mitochondria-in-breast-cancer-internal-motility-and-intercellular-transfer-of-mitochondria/335409/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-movement-of-mitochondria-in-breast-cancer-internal-motility-and-intercellular-transfer-of-mitochondria/335409.png","ImageObject",300,407,{"name":42,"@type":43},"Sage","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How do mitochondria movement and trafficking relate to breast cancer progression?","Question",{"text":63,"@type":64},"Mitochondria reposition within cells to meet areas of high energetic demand and can also move between cells. Intercellular transfer contributes to breast cancer progression by altering malignant behavior.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What mechanisms enable intercellular mitochondrial transfer?",{"text":68,"@type":64},"The document highlights that stromal cells can donate mitochondria to breast cancer cells via multiple methods, including tunneling nanotubes. This transfer is presented as a key route for mitochondrial exchange within tumor microenvironments.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is mitochondrial transfer associated with therapy resistance?",{"text":72,"@type":64},"Donated mitochondria are described as increasing both aggressiveness and chemoresistance of breast cancer cells. This association drives current work to uncover the mechanisms of mitochondrial transfer.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335409,1790916245,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Clinical & Experimental Metastasis (2024) 41:567–587 [https://doi.org/10.1007/s10585-024-10269-3](https://doi.org/10.1007/s10585-024-10269-3)  \nThe movement of mitochondria in breast cancer: internal motility and intercellular transfer of mitochondria  \nSarah Libring1 · Emily D. Berestesky1 · Cynthia A. Reinhart‑King1  \nReceived: 18 August 2023 / Accepted: 18 January 2024 / Published online: 15 March 2024 © The Author(s) 2024  \nAbstract  \nAs a major energy source for cells, mitochondria are involved in cell growth and proliferation, as well as migration, cell fate decisions, and many other aspects of cellular function. Once thought to be irreparably defective, mitochondrial function in cancer cells has found renewed interest, from suggested potential clinical biomarkers to mitochondria-targeting therapies. Here, we will focus on the effect of mitochondria movement on breast cancer progression. Mitochondria move both within the cell, such as to localize to areas of high energetic need, and between cells, where cells within the stroma have been shown to donate their mitochondria to breast cancer cells via multiple methods including tunneling nanotubes. The donation of mitochondria has been seen to increase the aggressiveness and chemoresistance of breast cancer cells, which has increased recent efforts to uncover the mechanisms of mitochondrial transfer. As metabolism and energetics are gaining attention as clinical targets, a better understanding of mitochondrial function and implications in cancer are required for developing effective, targeted therapeutics for cancer patients.  \nKeywords Breast cancer · Mitochondria · mtDNA · Tunneling nanotubes · Mitochondrial transfer  \nIntroduction  \nBreast cancer is the most commonly diagnosed cancer globally, with approximately 2.3 million new cases and 685,000 deaths in women in 2020 [1] . 5-year overall survival is > 80% if diagnosed at stage I or II (American Joint Commission on Cancer Staging, 6th edition), but was 63.4% for individuals diagnosed at stage III and 22.8% at stage IV using the 2006–2010 Surveillance, Epidemiology, and End Results (SEER) data [2] . In 2011, Hanahan and Weinberg expanded the hallmarks of cancer to include reprogramming cellular metabolism. Cancer cells have long been known to prefer glycolysis over oxidative phosphorylation (OXPHOS) even in the presence of oxygen (i.e. aerobic glycolysis), which is termed “the Warburg Effect” and has been successfully utilized in clinical scans for decades [3, 4] . Aerobic glycolysis has been associated with c-MYC and RAS amplifications and with loss of TP53, while increased  \n* Cynthia A. Reinhart-King [Cynthia.reinhart-king@vanderbilt.edu](Cynthia.reinhart-king@vanderbilt.edu)  \n1 Department of Biomedical Engineering, Vanderbilt University, 440 Engineering and Science Building, 1212 25thAvenue South, Nashville, TN 37235, USA  \nglycolysis in general can also be attributed to hyperplasia and the hypoxic cores associated with advanced tumors [3, 5] . As such, metabolic reprogramming varies across breast cancer molecular subtype depending on the most common oncogenic drivers and phenotypic presentation of each. For example, triple negative breast cancer cells have the highest expression of GLUT1 (glucose transporter 1) and display the most dramatic switch from mitochondrial respiration to glycolytic energy production across the molecular subtypes [5] . First proposed by Warburg himself, the prevailing hypothesis was that aerobic glycolysis in tumor cells occurred due to irreversible defects in the mitochondria.  \nHowever, advances in the last 25 years have revealed that many cancer cells still retain the capacity for OXPHOS during disease progression [6, 7] . For example, glycolysis inhibitors tested did not have as significant of an effect on tumor growth as expected. Additionally, increased OXPHOS is often seen in cancer stem cells and cancer cells resistant to chemotherapy [8] . These observations suggest that tumors are","cbCaieiPWvWbx4QJ","https://ap.wps.com/l/cbCaieiPWvWbx4QJ","pdf",1219750,21,"English","# Abstract\n# Introduction\n## Breast cancer and metabolic reprogramming\n## Mitochondrial function and cancer progression\n# Mitochondrial basics\n## Mitochondrial structures","[{\"question\":\"How do mitochondria movement and trafficking relate to breast cancer progression?\",\"answer\":\"Mitochondria reposition within cells to meet areas of high energetic demand and can also move between cells. Intercellular transfer contributes to breast cancer progression by altering malignant behavior.\"},{\"question\":\"What mechanisms enable intercellular mitochondrial transfer?\",\"answer\":\"The document highlights that stromal cells can donate mitochondria to breast cancer cells via multiple methods, including tunneling nanotubes. This transfer is presented as a key route for mitochondrial exchange within tumor microenvironments.\"},{\"question\":\"Why is mitochondrial transfer associated with therapy resistance?\",\"answer\":\"Donated mitochondria are described as increasing both aggressiveness and chemoresistance of breast cancer cells. This association drives current work to uncover the mechanisms of mitochondrial transfer.\"}]","The movement of mitochondria in breast cancer - internal motility and intercellular transfer of mitochondria | PDF",1790010859,53]